Dr. Oh is a medical oncologist with decades of experience caring for patients with prostate cancer. At Yale, he is building a cohesive program in precision medicine, integrating basic and translational science, clinical trials, and Smilow Cancer Hospital’s Precision Medicine Tumor Board. He is committed to increasing the utility and understanding of molecular testing for all cancer patients. Before joining Yale, Dr. Oh served as the Chief Medical Officer and Executive Vice President of the Prostate Cancer Foundation, where he focused on barriers to the delivery of care for prostate cancer nationally. He also served as CMO for Sema4, a patient-centered health intelligence company. For over a decade, Dr. Oh was Chief of Hematology and Medical Oncology, Deputy Director of the NCI-designated Tisch Cancer Institute and the Ezra Greenspan, MD Professor of Clinical Cancer Therapeutics at Icahn School of Medicine at Mount Sinai. He began his professional career at Dana-Farber Cancer Institute and Harvard Medical School, including roles as Clinical Director of the Lank Center for Genitourinary Oncology and Director of the Gelb Center for Translational Medicine.